Ensysce Biosciences, Inc. (ENSC) › Shareholders' EquityEnsysce Biosciences, Inc. (ENSC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $5.00M2018: $5.00M2019: $5.00M2020: -$6.44M2021: -$7.88M2022: -$3.71M2023: -$322.9K2024: $3.71M2025: $3.21M$3.21M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$3.21M-13.3%2024$3.71M+1248.6%2023-$322.9K+91.3%2022-$3.71M+52.9%2021-$7.88M-22.3%2020-$6.44M-228.8%2019$5.00M+0.0%2018$5.00M+0.0%2017$5.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share